These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19746575)

  • 1. Type 2 diabetes: target HbA1c of about 7%.
    Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher type 2 diabetes-related mortality when HbA1c levels are too low.
    Prescrire Int; 2008 Oct; 17(97):213. PubMed ID: 19536943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 10-year follow-up of intensive glucose control in type 2 diabetes.
    Holman RR; Paul SK; Bethel MA; Matthews DR; Neil HA
    N Engl J Med; 2008 Oct; 359(15):1577-89. PubMed ID: 18784090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A summary of the ADVANCE Trial.
    Heller SR;
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S357-61. PubMed ID: 19875581
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glycaemic control and complications of diabetes: what about?].
    Bouhanick B; Barigou M; Kantambadouno JB; Chamontin B
    Presse Med; 2013 May; 42(5):849-54. PubMed ID: 23540378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes and HbA1c targets.
    Prescrire Int; 2008 Dec; 17(98):254. PubMed ID: 19425272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes specialists keep ACCORD data in perspective.
    Traynor K
    Am J Health Syst Pharm; 2008 Mar; 65(6):488, 490. PubMed ID: 18319488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tough glucose reduction necessary in newly diagnosed diabetes].
    Rydén M
    Lakartidningen; 2010 Nov 10-16; 107(45):2810-4. PubMed ID: 21179867
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
    Meier M; Hummel M
    Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].
    Scheen AJ; Paquot N; Lefebvre PJ
    Rev Med Liege; 2008 Oct; 63(10):624-9. PubMed ID: 19009971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose supply and insulin demand dynamics of antidiabetic agents.
    Monte SV; Schentag JJ; Adelman MH; Paladino JA
    J Diabetes Sci Technol; 2010 Mar; 4(2):365-81. PubMed ID: 20307399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aggressive and early combined drug therapy. Antidiabetics for prevention of myocardial infarct].
    MMW Fortschr Med; 2003 Jun; 145(25):52. PubMed ID: 12891856
    [No Abstract]   [Full Text] [Related]  

  • 14. [Certain beginning of insulin therapy: yes, we can, but...].
    Rohrer A
    Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117
    [No Abstract]   [Full Text] [Related]  

  • 15. [Critical questions on diabetes therapy and their sequelae. HbA1c: may it be more than 7 after all?].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):14-6. PubMed ID: 19938773
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UKPDS and the legacy effect.
    Chalmers J; Cooper ME
    N Engl J Med; 2008 Oct; 359(15):1618-20. PubMed ID: 18843126
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on the Canadian Diabetes Association 2008 clinical practice guidelines.
    Bhattacharyya OK; Estey EA; Cheng AY;
    Can Fam Physician; 2009 Jan; 55(1):39-43. PubMed ID: 19155364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glycemic control and diabetic complications].
    Yamada Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():604-8. PubMed ID: 15999778
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].
    Reblin T; Seidel D; Stein D; Görtz A; Lander T
    MMW Fortschr Med; 2003 May; 145(19):41. PubMed ID: 12813977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.